Richard Meijer

Full Professor

Strategic program(s):

Biography

2025-present	Professor Oncological Urology, UMC Utrecht
2021-present	Chairman UMC Utrecht Expertise Centre for testicular and extragonadal germ cell tumors (NFU and ERN eUROGEN)
2018-present	Head Department Oncological Urology, UMC Utrecht
2018-present	Associate Professor Oncological Urology, UMC Utrecht
2012-present	Oncological Urologist, UMC Utrecht
2016-present	Chairman of the Oncological Urology Tumour Group, UMC Utrecht
2016-present	Member of the Oncology Committee, UMC Utrecht
2016-present	Deputy Chief of the Specialist Medical Training Urology, UMC Utrecht

Current research projects

Research support (institutional)

Janssen (Research-grant) (2017-2022)
Roche (Research-grant) (2017-2021)
Astellas (Research-grant) (2021-2022)
Merck (Educational-grant) (2022)
Janssen/Astellas/AstraZeneca/MSD/BMS/Roche/Merck (ProBCI support)

Company Advisory Boards (institutional):

Merck
MSD
Janssen
Bristol-Myers Squibb Company

2023 Framingham selection Urothelial Cancer Issues (Bristol-Myers Squibb Company; institutional)

Strategic program(s):

Contact

rmeijer6@umcutrecht.nl

Pure profile

Research groups

Translational oncology

Research aim

To develop, test, and implement novel therapeutic and diagnostic strategies to combat cancer by integrating fundamental and clinical research.

Go to group

Uro-oncology research group

Research aim

Pioneering precise diagnostics in urologic oncology research, employing cutting-edge imaging modalities and genetic profiling for early detection and personalized treatment strategies, revolutionizing patient care and outcomes.

Go to group

Recent publications

All publications

Influence of Artificial Intelligence Assistance on Gleason Grading and Prostate Cancer Detection by Uropathologists in Daily Practice Jacqueline E van Hees, Paul J van Diest, Tri Q Nguyen, Mitchell G Lynch, Trudy N Jonges, Richard P Meijer, Peter-Paul M Willemse, Britt B M Suelmann, Carmen van Dooijeweert
JCO clinical cancer informatics, 2026, vol. 10

The CAMUS Initiative Christopher Soliman, Niranjan J. Sathianathen, Niall M. Corcoran, Nathan Lawrentschuk, Patrick Y. Wuethrich, Marc A. Furrer, Furat Abd Ali, Muhammad Fairuz Shah Bin Abd Karim, Mohamed Abouelenein, Yasmin Abu Ghanem, Ahmed Adam, Alessandro Adami, Konstantinos Adamos, Constantinos Adamou, Ademola Adeyeye, Florian Aellen, Luca Afferi, Abhishek Agarwal, Dinesh K. Agarwal, Vandana Agarwal, Edoardo Agostini, Mayank Agrawal, María Ángela Agüera Sánchez, Sarfraz Ahmad, Rawdy Talaat Ahour, Ilgar Akbarov, Samira Akbas, Nebil Akdogan, Eren Erdi Aksaray, Osama Al-Bermani, Rouvier Al-Monajjed, Dheaa Al-Rammahi, David M. Albala, Peter Albers, Peter C. Albertsen, Salah Albuheissi, Hassan Aina Ali, Mohamed Ali Ibrahim Ali Mohsen, Axel Bex, Joost M. Blok, Yu Chen Chen, G. Georgiadis, Nick Julius Koning, Richard P. Meijer, Timo Soeterik, Roderick van den Bergh, Henk G. van der Poel, Bas WG van Rhijn, Michiel Vlaming, Charlotte S. Voskuilen,
European Urology Open Science, 2026, vol. 87, p.57-70

Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer J Bosveld, B B M Suelmann, M J Bijlsma, M D Franken, K K H Aben, R P Meijer, A Richters,
ESMO Real World Data and Digital Oncology, 2026, vol. 11

Nieuwe ontwikkelingen bij blaaskanker Joost L. Boormans, Richard P. Meijer
Tijdschrift voor Urologie, 2026, vol. 16, p.21

Spierinvasieve blaaskanker in Nederland Katharina Brück, Richard P. Meijer, Joost L. Boormans, Lambertus A. Kiemeney, J. Alfred Witjes, Lisa M.C. van Hoogstraten, Michiel S. van der Heijden, A. Rogier Donders, Martine Franckena, Carin A. Uyl-de Groot, Annemarie M. Leliveld-Kors, Katja K.H. Aben, Maarten C.C.M. Hulshof,
Tijdschrift voor Urologie, 2026, vol. 16, p.59-67

The impact of positive surgical margins after cystectomy on oncological outcomes Jikke Bosveld, Tri Q. Nguyen, Joost L. Boormans, Antoine G. van der Heijden, Niven Mehra, Lambertus A. Kiemeney, Katja K.H. Aben, Richard P. Meijer, Anke Richters,
Tijdschrift voor Urologie, 2026, vol. 16

External positions

Panelmember EAU Muscle-invasive and Metastatic Bladder Cancer (MIBC) Guidelines Panel - Aandachtsgebied blaaskanker - European Association of Urology

Panelmember EAU Guideline Primary Urethral Carcinoma - Europese richtlijn commissie - European Association of Urology

Stuurgroep ProBCI - Blaaskanker expertise - Stichting Prospectieve Blaaskanker Infrastructuur (ProBCI)

Plaatsvervangend opleider Urologie UMCU - Plaatsvervangend opleider Urologie UMCU - UMCU

Associate member of ERUS (EAU Robotic Urology Section) - Associate member of ERUS (EAU Robotic Urology Section) - European Association of Urology

Voorzitter UMC Utrecht Expertise Centrum voor testiculaire en extragonadale - Voorzitter UMC Utrecht Expertise Centrum voor testiculaire en extragonadale NFU accreditatie (ECZA) - UMCU

Lid van Dutch Uro-Oncological Society (DUOS) - Actief lid van de subgroepen blaaskanker en zaadbalkanker van de DUOS - Dutch Uro-Oncological Society (DUOS)

Lid Werkgroep Oncologische Urologie (WOU) van de NVU - Actief lid van de subgroepen blaaskanker en zaadbalkanker van de Werkgroep Oncologische Urologie (WO - Nederlandse Vereniging voor Urologie

Associate member of ESOU (EAU Section of Oncological Urology) - Associate member of ESOU (EAU Section of Oncological Urology) - European Association of Urology